Institute of Good Manufacturing Practices India
Conferment of QCI - D.L. Shah National Quality Award to IGMPI
Hon'ble Dr GN Singh, Drug Controller General of India presented a Momento by IGMPI on the launch of our Computer Validation (CSV) program
Dr. APJ Kalam,Hon'ble Former President releasing our Lab World Magazine with our Principal Advisor, Editor Dr Mahesh Gupta
Hon'ble Prime Minister of India, Shri Narendra Modi congratulating Media Advisor, IGMPI- Shri Samir Abbas on his initiative
Conferment of ASSOCHAM Services Excellence Award 2017 to IGMPI
IGMPI honoured as the Jury (yet again) for the FDD Leadership Awards
FDD Leadership Awards 2018 Conferment by Mr Vinod Arora, Principal Advisor, IGMPI
Mr Vinod Arora, Principal Advisor, IGMPI (Moderator)
Whose work ideology revolves around its sole vision to make available efficient professionals to the Industry
Targeting to fill up the gap between the existing and accessible knowledge
Whose work ideology revolves around its sole vision to make available efficient professionals to the Industry
With the values of Quality, Flexibility, Excellence and Professionalism
Whose work ideology revolves around its sole vision to make available efficient professionals to the Industry
Targeting to fill up the gap between the existing and accessible knowledge
Educating todays learners for tomorrows world
Whose work ideology revolves around its sole vision to make available reliable and efficient professionals to the Industry
Educating todays learners for tomorrows world
FSSAI Food Safety Training, HACCP & FSMS training by IGMPI
FSSAI Food Safety Training, HACCP & FSMS training by IGMPI
FSSAI Food Safety Training, HACCP & FSMS training by IGMPI
FSSAI Food Safety Training, HACCP & FSMS training by IGMPI
Indian pharma companies looking at WHO-GMP norms for quality standards
More and more companies are looking at upgrading their facilities as per the World Health Organisation-Good Manufacturing Practices (WHO-GMP) norms to meet quality standards. According to the Indian Drug Manufacturers’ Association (IDMA) the Centre is likely to incentivize the upgradation of Schedule M facilities to WHO-GMP compliant units through scheme of soft loans.
This move can see an extra 1,000 pharma manufacturing facilities, mainly small and medium enterprises (SMEs), to upgrade to WHO-GMP compliance within a year. The overall pharma contract manufacturing industry in the country is growing at 20 per cent. Currently, MNCs enjoy around 20-25 per cent market share of the overall Rs 77,000 crore domestic pharma market and nearly two-thirds of their production comes from contract manufacturing.
Another 1,000 units can easily upgrade themselves to WHO-GMP status within the next one year if the government incentive comes through. At present only 10 per cent of all manufacturing units in the country are WHO-GMP compliant. This presents a huge opportunity before the SMEs towards upgrading the manufacturing facilities to meet WHO-GMP standards.
Pharmaceuticals | Food | Clinical Research | Healthcare | Medical Coding | Medical Device | Nanotechnology | IPR
GLOBALG.M.P.™ NEWSLETTER
Featured Article
Mr Vinod Arora, Principal Advisor, IGMPI
Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like